Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our customタンパク質 services!
カスタムサービスについてのお問い合わせはこちら >>
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| PA1-HF2G5 | Human | Fluorescent Human PAR1 Full Length Protein (VLP) | |||
| PA1-H52P6 | Human | Human PAR1 Full Length Protein (VLP) |
Immobilized Human PAR1 Full Length Protein-VLP (Cat. No. PA1-H52P6) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human PAR1 antibody, Mouse IgG1 with a linear range of 0.1-1.3 μg/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Vorapaxar Sulfate | MK-5348; TRA-SCH-530348; SCH-530348 | Approved | Merck Sharp & Dohme Corp | Zontivity | United States | Coronary Thrombosis; Myocardial Infarction; Peripheral Arterial Disease; Thrombosis | Xspire Pharma | 2014-05-08 | Myocardial Ischemia; Myocardial Infarction; Atherosclerosis; Arterial Occlusive Diseases; Stroke; Acute Coronary Syndrome; Coronary Thrombosis; Coronary Disease; Arteriovenous Fistula; Ischemia; Peripheral Arterial Disease; Thrombosis; Cerebral Infarction | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| PZ-128 | PZ-128 | Phase 2 Clinical | Tufts Medical Center Inc | Myocardial Ischemia; Arterial Occlusive Diseases; Heart Diseases; Coronary Artery Disease; Acute Coronary Syndrome; Vascular Diseases; Coronary Disease; Arteriosclerosis | Details |
| Rusalatide | TRAP-508; TP-508 | Phase 1 Clinical | Baylor College Of Medicine, University Of Texas Medical Branch | Respiratory Distress Syndrome, Adult; Radius Fractures | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
